InterVenn Bioscience

[On Demand]
Search General Info
Search Education
Search Partnering Companies
InterVenn's proprietary technology platform combines the molecular resolution of mass spectrometry with the power of an AI-driven data processing engine to interrogate the glycoproteome at a scale and throughput that, for the first time, allows glycoproteomics to be applied to clinically actionable applications.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
predictive tests for ovarian cancer and immuno-therapy treatment response
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4-6
Speaker
photo
CSO/CMO
InterVenn Biosciences